Market-Weighted Healthcare or Active Manager Selection? IYH vs. PINK

Source Motley_fool

Key Points

  • Simplify Health Care ETF carries a higher expense ratio but has significantly outperformed iShares U.S. Healthcare ETF over the past year

  • iShares U.S. Healthcare ETF offers a higher dividend yield and lower price volatility as measured by its lower historical beta

  • The Simplify fund follows an active mission-driven strategy targeting innovation while the iShares fund provides passive exposure to 102 healthcare stocks

  • 10 stocks we like better than iShares Trust - iShares U.s. Healthcare ETF ›

Simplify Health Care ETF (NYSEMKT:PINK) offers an active, thematic approach with a philanthropic focus, while iShares U.S. Healthcare ETF (NYSEMKT:IYH) provides broad, passive market access to the industry established giants.

Healthcare exchange-traded funds can serve as defensive anchors or aggressive growth engines, depending on their underlying strategy. While both funds provide exposure to the medical sector, they vary significantly in their selection criteria, management styles, and cost structures. The PINK fund targets innovation with a pro bono twist, whereas IYH mirrors a traditional market-cap-weighted index.

Snapshot (cost & size)

MetricPINKIYH
IssuerSimplifyiShares
Expense ratio0.51%0.38%
1-yr return (as of June 8, 2026)29.30%15.30%
Dividend yield0.66%1.28%
Beta0.740.57
AUM$266.96 million$3.12 billion

Cost-conscious investors may find the iShares U.S. Healthcare ETF more appealing due to its 0.38% expense ratio, which is lower than the 0.51% charged by PINK. These differences in fees and distributions can impact long-term total returns and assets under management (AUM) efficiency.

Performance & risk comparison

MetricPINKIYH
Max drawdown (4 yr)(18.80%)(17.90%)
Growth of $1,000 over 4 years (total return)$1,545$1,261

What's inside

iShares U.S. Healthcare ETF (NYSEMKT:IYH) is heavily exposed to large pharmaceutical, biotechnology, healthcare equipment, managed-care, and life sciences companies.This passive fund holds roughly 100 stocks, and its largest positions include Eli Lilly (NYSE:LLY) at 16.17%, Johnson & Johnson (NYSE:JNJ) at 9.81%, and AbbVie (NYSE:ABBV) at 6.94%. Launched in 2000, it is an established vehicle for healthcare exposure and has paid $0.81 per share over the trailing 12 months. It does not utilize specialized strategies like currency hedging and focuses primarily on market-cap-weighted domestic leaders.

By contrast, Simplify Health Care ETF (NYSEMKT:PINK) is an actively managed fund launched in 2021 that maintains a more concentrated portfolio of roughly 58 holdings. Its allocation includes 90.00% in healthcare and 10.00% in industrials, focusing on pioneering sub-sectors like biotechnology and gene therapy. Its largest positions include PureCycle Technologies (NASDAQ:PCT) at 10.05%, United Therapeutics (NASDAQ:UTHR) at 7.24%, and Novo Nordisk (NYSE:NVO) at 6.06%. The fund has a trailing-12-month dividend of $0.25 per share. It features a unique mission-driven quirk where management donates its net profits to breast cancer research and incorporates a currency hedge into its strategy.

For more guidance on ETF investing, check out the full guide at this link.

What this means for investors

Healthcare ETFs can give investors exposure to the same broad industry while taking very different approaches to what they actually own. That matters with IYH and PINK because the comparison is not just about healthcare exposure, fees, or yield. The real distinction is whether investors want a passive fund that reflects the market's sector weights or an active strategy built around a manager’s more selective view of healthcare.

The iShares U.S. Healthcare ETF offers a traditional, passive approach, providing broad exposure to major U.S. healthcare industries such as pharmaceuticals, biotechnology, medical equipment, managed care, and life sciences. In contrast, the Simplify Health Care ETF (PINK) is actively managed, more concentrated, and may differ significantly from broad healthcare benchmarks. While PINK’s donation of net management profits to Susan G. Komen is notable, this feature should be considered separately from its investment merits.

Investors must choose between broad benchmark exposure and active manager selection. Both funds face industry risks such as healthcare policy, drug pricing, product cycles, and sector valuations. IYH is more suitable for investors seeking diversified, low-cost access to established U.S. healthcare companies. PINK is better for investors comfortable with a concentrated, actively managed strategy that relies on individual holdings and manager expertise.

Should you buy stock in iShares Trust - iShares U.s. Healthcare ETF right now?

Before you buy stock in iShares Trust - iShares U.s. Healthcare ETF, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and iShares Trust - iShares U.s. Healthcare ETF wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $415,040!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,256,076!*

Now, it’s worth noting Stock Advisor’s total average return is 920% — a market-crushing outperformance compared to 207% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.

See the 10 stocks »

*Stock Advisor returns as of June 18, 2026.

Eric Trie has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
Will the Tech Rally Continue? The Technical Verdict on the NASDAQ 100 Riding a massive 32% post-earnings wave, the Nasdaq-100 is showing its first signs of exhaustion. We break down crucial exit and entry rules for long positions this week.
Author  Mitrade Team
6 Month 05 Day Fri
Riding a massive 32% post-earnings wave, the Nasdaq-100 is showing its first signs of exhaustion. We break down crucial exit and entry rules for long positions this week.
placeholder
US Futures Edge Up Post-Rout Despite Iran-Israel Clash and Hawkish Fed RisksU.S. equity futures stabilized Sunday as tech shares attempted a recovery, though gains were capped by escalating Middle East hostilities and fears of prolonged Federal Reserve monetary tightening.
Author  Mitrade Team
6 Month 08 Day Mon
U.S. equity futures stabilized Sunday as tech shares attempted a recovery, though gains were capped by escalating Middle East hostilities and fears of prolonged Federal Reserve monetary tightening.
placeholder
WTI steadies around $87.50 despite renewed supply concernsWest Texas Intermediate (WTI) oil price experiences volatility after registering over 2.5% losses in the previous day, trading around $87.40 per barrel during the Asian hours on Wednesday.
Author  Mitrade Team
6 Month 10 Day Wed
West Texas Intermediate (WTI) oil price experiences volatility after registering over 2.5% losses in the previous day, trading around $87.40 per barrel during the Asian hours on Wednesday.
placeholder
15 Days After SpaceX Listing, Index Funds Will Take 30% of Floating Shares, What It Means for Retail Investors?TradingKey - SpaceX (SPCX.US) is set to debut on Nasdaq on June 12, targeting a valuation of $1.75 trillion. At that time, only about 3% to 4% of total shares will be freely tradable; with founder sha
Author  Mitrade Team
6 Month 10 Day Wed
TradingKey - SpaceX (SPCX.US) is set to debut on Nasdaq on June 12, targeting a valuation of $1.75 trillion. At that time, only about 3% to 4% of total shares will be freely tradable; with founder sha
placeholder
Gold Price Analysis (XAU/USD): Gold Falls to 6-Month Low as Inflation Fuels Rate Hike Bets, A Buying Opportunity or a Falling Knife? Gold hit a 6-month low on Fed rate hike bets. However, strong central bank buying and technical indicators suggest potential tactical bounces and long-term accumulation windows.
Author  Mitrade Team
6 Month 12 Day Fri
Gold hit a 6-month low on Fed rate hike bets. However, strong central bank buying and technical indicators suggest potential tactical bounces and long-term accumulation windows.
goTop
quote